Thorne Quercetin Phytosome
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Evidence update: Curcumin is not a proven human senolytic, and laboratory pathway effects do not establish clinical benefit.
Curcumin is not a primary senolytic in the BCL-2 family inhibition sense, but its potent NF-κB inhibition directly suppresses SASP production from existing senescent cells. Additionally, curcumin activates autophagy (mTOR inhibition + Beclin-1 upregulation) and shows BCL-2 modulation at concentrations achievable with high-bioavailability formulations.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
8 mg fisetin per capsule
Low-dose fisetin with fenugreek galactomannans.
Best for: reviewing a low-dose fisetin label in Key Facts
View on Amazon · Affiliate link
Can curcumin replace quercetin in a senolytic protocol?
No. Curcumin's SASP suppression is complementary but cannot substitute for quercetin's direct BCL-2 inhibition (senolytic mechanism). Curcumin is an excellent daily anti-SASP supplement alongside a quercetin + fisetin senolytic protocol.
What curcumin form is best for senolytic purposes?
High-bioavailability forms that achieve plasma concentrations closest to the BCL-2 modulation range: BCM-95, Longvida, NovaSol (reported 185x improvement), or Meriva phytosome. Standard powder/extract is inadequate.
Curcumin affects inflammatory and cell-signaling pathways in laboratory experiments, but concentrations used in cells may not be reached in human tissues after oral supplements. Reduced NF-κB signaling or a change in a cytokine does not prove that senescent cells were selectively removed. Human curcumin trials generally address other outcomes and do not establish a senolytic protocol or lifespan benefit.
Bioavailability varies substantially across products; piperine and other enhancers can also change drug metabolism. Curcumin may be unsuitable for people with gallbladder or bile-duct disease, bleeding risk, or medicines affected by interactions. Ask a pharmacist before combining concentrated extracts with anticoagulants, antiplatelet drugs, or cancer treatment. Do not use curcumin instead of indicated medical care.
FAQ — Can curcumin replace fisetin or D+Q? No comparative human trial supports that claim.
Research context: Review search: curcumin and cellular senescence; NCCIH turmeric safety information.